Introduction
============

Endothelial cell apoptosis is an important mechanism of endothelial dysfunction, during heart failure. Moreover, activation of nerve endocrine system, inflammatory factors, oxidative factors and apoptosis factor could significantly affect the severity of heart failure ([@b1-etm-0-0-5079],[@b2-etm-0-0-5079]). Prostaglandin A1 (PGA1) and triptolide (TRI) could inhibit the extensive replication of various DNA/RNA viruses and are related to the transcription of apoptosis factors B-cell lymphoma 2 (Bcl-2) ([@b3-etm-0-0-5079]--[@b5-etm-0-0-5079]). Upregulation of Bcl-2 expression is an improvement in cell apoptosis.

In the present study, cardiac microvascular endothelial cells (CMVECs) were isolated and cultured. After MTT test, appropriate hypoxia and oxygen time points were selected. PGA1 and TRI were then given intervention cells. Terminal deoxynucleotidyl transferase (TUNEL) along with quantitative polymerase chain reaction (qPCR) methods were used to study the effects of PGA1 and TRI on CMVECs cells, in order to reveal the molecular mechanism of endothelial cells. The present study provides a new approach for the protection of endothelial cells and the treatment of myocardial ischemia reperfusion injury.

Materials and methods
=====================

### Experimental animals

Male Sprague-Dawley rats (5--7 days, weighing 200±20 g, purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd., Beijing, China) were selected, at room temperature 25±2°C, with free access to food and water. CMVECs cells were extracted.

### Main reagents

Cell culture medium, fetal bovine serum (FBS) and trypsin powder were all purchased from Gibco (New York, NY, USA). The CA Protein Quantification kit was obtained from Bi Yuntian (Shanghai, China). Rabbit anti-rat CD31 monoclonal antibody was obtained from CST (Boston, MA, USA). RNAiso Plus, PrimeScript^®^ RT reagent kit with gDNA Eraser (Perfect Real-Time) and SYBR^®^ Premix Ex Taq™ II (Tli RNaseH Plus) both purchased from Bao Biological (Dalian, China). *In situ* end-labeling assay for cell apoptosis was obtained from Roche (Basel, Switzerland). Anti Bcl-2 rabbit anti-rat monoclonal antibodies and immunofluorescence secondary antibody both from CST.

### Culture of rat CMVECs

The rats were anesthetized by ether inhalation. After a further bath disinfection, the chest of rats was opened for the excision of hearts. The hearts were first placed in 4°C pre-cooling phosphate-buffered saline (PBS) liquid for cleaning. This was followed by cutting of the heart tissues into pieces. The bottom wall of the culture dish was dampened by 1 ml FBS and the tissue block was evenly distributed in the culture dish. The culture dish was placed in an incubator at 37°C. The culture medium 8 ml was added to the culture dish and was cultured for 24 h. Endothelial cell culture medium was changed after cells showed basic form. Cell culture was continued until culture grown to confluence state with 0.25% trypsin +EDTA digestion passage.

This study was approved by the Animal Ethics Committee of China-Japan Friendship Hospital Animal Center.

### Identification of rat CMVECs

CMVECs specific antigen CD31 gene was used to identify CMVECs by immunofluorescence. After trypsin digestion of the primary CMVECs, the cells were placed into a 25 mm Petri dish with pretreated coverslip on the bottom. After 2 days, cell growth basically covered the bottom plate. After washing with PBS, formaldehyde for the fixation was used for 15 min. BSA (5%) was added and the incubation was performed for 30 min at room temperature. PE anti-human CD31 (dilution, 1:70; cat. no. 320806; Biolegend, Shanghai, China) was added for incubation at 4°C overnight with PBS washing three times. The samples were observed under fluorescence microscope (IX70; Olympus, Tokyo, Japan) after PBS cleaning.

### Selection of oxygen supply time for cell hypoxia

Fused cells were randomly divided into the control group (normal oxygen), hypoxia 12 h/reoxygenation 3, 6 and 9 h group. First, the endothelial cells were placed in an anoxic culture box with a gas composition of 95% N~2~ + 5% CO~2~. After hypoxia for 12 h, the reoxygenation MTT experiment, the optimal hypoxia and reoxygenation intervention time point (hypoxia for 12 h/reoxygenation for 6 h was the best) was selected. The growth of good primary rat CMVECs was selected, according to the results of MTT. Cells were then randomly divided into the normoxic control group (C, normal oxygen), hypoxia reoxygenation group (H/R, hypoxia 12 h/reoxygenation 6 h), PGA1 group (H/R+PGA1), and TRI group (H/R+TRI).

### Quantitative PCR analysis

The collected CMVECs were transferred into the 1.5 ml reagent containing TRIzol and were placed at room temperature for 5 min. After centrifugation at 4°C for 5 min at 12,000 × g, the supernatant was carefully placed into a new Eppendorf (EP) tube. Chloroform (0.2 ml) was added to the supernatant, mixed evenly, and placed at room temperature for 5 min. Centrifugation was performed again for 15 min at 12,000 × g, at 4°C. Supernatant was absorbed into another new EP tube. The same volume of isopropanol was added after reversing several times with full mixing, and placed at room temperature for 10 min. Centrifugation was again performed for 10 min. The supernatant was discarded, for precipitation, 1 ml 75% ethanol was added, and mixed evenly, followed by 12,000 × g centrifugation at 4°C for 5 min. Supernatant was discarded and the process repeated. RNA concentration was then measured. The total RNA solution was diluted with RNase-free H~2~O into 1 µg/µl, according to PrimeScript^®^ RT reagent kit with gDNA Eraser reagent kit instructions. Prepared reverse transcription reaction liquid was added the corresponding RNA sample and the reverse transcription was performed to obtain cDNA. The cDNA was stored at −20°C. According to SYBR^®^ Premix Ex Taq™ II (Tli RNaseH Plus) reagent kit instructions, mRNA levels were determined. The corresponding RNA primer sequences are shown in [Table I](#tI-etm-0-0-5079){ref-type="table"}.

### Detection of apoptosis in CMVECs

The cells with 1×10^5^/ml (1.5 ml) concentration were inoculated in 24-well plates, cultured at 37°C medium, for grouping model. Cells of the normoxic control group (C, normal oxygen), hypoxia reoxygenation group (H/R, hypoxia 12 h/reoxygenation 60 h), PGA1 group (H/R+PGA 180 nmol/l) and TRI group (H/R+TRI 10 µg/l) were collected, respectively. The supernatant was removed and washed with PBS (PGA1 and TRI were used for the solution with Me~2~SO and normal saline was diluted to a final concentration of 5%, with microporous membrane for sterilization). Fixation was performed for 10 min with 10% paraformaldehyde in the 37°C incubator which was followed by washing with PBS. Permeabilization was then performed with a 0.1% Triton X-100 in the 37°C incubator for 10 min and washed with PBS. Using 5% skim milk for 1 h, TUNEL detection liquid was added. Incubation was then performed at 37°C for 1 h. After PBS washing, the nuclei were stained with DAPI (1:100) and observed under an inverted fluorescence microscope.

### Statistical analysis

The experimental results were analyzed using SPSS 17.0 statistical software (Chicago, IL, USA). The Student\'s t-test, and one-way ANOVA were used for comparisons between groups. P\<0.05, was considered to indicate a statistically significant difference.

Results
=======

### Observation and identification of CMVECs

Since the third day of isolation and culture of CMVECs, under the microscope, the cells were polygonal or diamond-shaped. After replacing the cell culture medium, the cells were cultured for 4 days and the cells were fused, and then cultured for 5 days. Fully fused cells are shown in [Fig. 1](#f1-etm-0-0-5079){ref-type="fig"}. Immunofluorescence CD31 staining was performed for cell identification, and a large number of CD31 positively stained cells were observed ([Fig. 2](#f2-etm-0-0-5079){ref-type="fig"}), suggesting that isolated cells were endothelial cells with high purity. In this study, second generations of stably growing cells were used for intervention.

### Hypoxia and reoxygenation time point by MTT method

The CMVECs cells were inoculated into a 96-well plate. After the normal adherent production of cells, the endothelial cells were placed in the anoxic culture box with a gas composition of 95% N~2~ + 5% CO~2~ and cultured in hypoxia for 12 h. Hypoxia and reoxygenation experiment was performed. The groups were: control group (normal oxygen, without any stimulation), and hypoxia 12 h/reoxygenation 3, 6 and 9 h/group. [Fig. 3](#f3-etm-0-0-5079){ref-type="fig"} shows that in hypoxia for 12 h/reoxygenation for 3 h, the activity of the cells was \>80%, in hypoxia for 12 h/reoxygenation for 6 h, cell viability decreased significantly, and the activity of cells was approximately 50%, while in hypoxia 12 h/reoxygenation 9 h group, cell activity was \<30% and most of the cells died. Thus, the selection of hypoxia for 12 h/reoxygenation for 12 h was the optimal hypoxia and reoxygenation time point and the next experimental study followed.

### TUNEL detection of CMVEC apoptosis ratio of different intervention groups

As shown in [Fig. 4](#f4-etm-0-0-5079){ref-type="fig"}, almost no TUNEL-labeled positive cells were found in the CMVECs blank control group, suggesting that CMVECs normally had no apoptosis. Compared with the control group, a large number of TUNEL-labeled positive cells appeared in the CMVECs after hypoxia and reoxygenation, suggesting that the apoptosis rate increased significantly ([Fig. 4](#f4-etm-0-0-5079){ref-type="fig"}, P\<0.01). The apoptosis rates of CMVECs decreased significantly after intervention of PGA1 and TRI ([Fig. 4](#f4-etm-0-0-5079){ref-type="fig"}, P\<0.01). Thus, PGA1 and TRI significantly reduced cell apoptosis.

### Effects of PGA1 and TRI on the expression of Bcl-2 mRNA

As shown in [Fig. 5](#f5-etm-0-0-5079){ref-type="fig"}, compared with the blank control group, Bcl-2 mRNA expression of CMVECs significantly reduced after oxygen stimulation (P\<0.05). The expression of Bcl-2 after PGA1 and TRI intervention significantly increased. Moreover, the elevated effect of PGA1 was better than that of TRI.

Discussion
==========

In recent years, with the rapid development of cardiac surgery, myocardial ischemia reperfusion injury has been the focus of active study ([@b6-etm-0-0-5079]). Previous studies have shown that by the inhibition of inflammation, oxidative stress and apoptosis could significantly alleviate myocardial ischemia-reperfusion injury ([@b7-etm-0-0-5079]). In this study, PGA1 and triptolide alcohol *in vivo* (TRI) significantly inhibited microvascular endothelial cell (CMVECs) apoptosis and significantly decreased the expression of Bcl-2 mRNA, to inhibit apoptosis of CMVECs. This suggested that PGA1 and TRI could improve the cell injury and play a protective role of CMVEC apoptosis in rats.

Donor heart ischemia reperfusion injury after cardiac transplantation is the process of affecting the survival of transplanted hearts. Although many factors contribute to the cause of ischemia reperfusion injury, the downregulation of the apoptosis factor and the promotion of apoptosis factor expression play an important role in reperfusion injury ([@b8-etm-0-0-5079],[@b9-etm-0-0-5079]). Previous studies have shown that in endothelial cell injury a large number of apoptotic bodies are produced and the Bcl-2 plays a crucial role ([@b10-etm-0-0-5079]). Bcl-2 is an important inhibitor of apoptosis and could inhibit cell death caused by various cytotoxic factors ([@b11-etm-0-0-5079]). Bcl-2 not only acts on cancer cells in stage G2/M and participates in apoptosis, but also significantly enhances the expression of mutant p53 and Bax proteins in cells ([@b12-etm-0-0-5079]). The value-added process of endothelial cells is determined by a series of rules of gene regulation. Apoptosis is the only way to renew cells. Apoptosis of endothelial cells after ischemia reperfusion injury may be due to the severe downregulation of anti-apoptotic factor Bcl-2 ([@b13-etm-0-0-5079],[@b14-etm-0-0-5079]). In that study through the *in vitro* culture of CMVEC cells PGA1 and TRI intervention therapy was administered, suggesting that PGA1 and TRI significantly improved the decreased expression of Bcl-2 mRNA induced by myocardial ischemia reperfusion. The TUNEL experimental results showed that the damage of DNA also had significant improvement. This experiment proved the importance of Bcl-2 in heart ischemia reperfusion, and laid the foundation for further mechanism research.

PGA1 is a kind of cyclization of 20 carbon fatty acids with many biological activities ([@b15-etm-0-0-5079]). Clinical application of PGA1 on essential hypertension, renal hypertension, diabetic hypertension and pheochromocytoma hypertension has significant antihypertensive effect. It has been reported that PGA1 had potent anti-inflammatory effects ([@b16-etm-0-0-5079],[@b17-etm-0-0-5079]). TRI is two mushroom complex compound containing epoxy isolated from *Tripterygium wilfordii* ([@b18-etm-0-0-5079]). TRI has a strong physiological activity, widely used in clinical research and research shows that it has antioxidant, anti-rheumatoid, anti-Alzheimer\'s disease, anticancer and other effects ([@b19-etm-0-0-5079]). It is reported that TRI has anti-inflammatory, anti-oxidation and inhibitory effects on apoptosis ([@b20-etm-0-0-5079]). However, the relationship between PGA1, TRI and ischemia reperfusion is not understood well. Through TUNEL apoptosis staining and qPCR experiments, we found that PGA1 and TRI had a strong protective effects on CMVECs cell injury induced by hypoxia reperfusion (the protective effect of PGA1 was stronger than that of TRI). These results provided a new direction of treatment to myocardial ischemia reperfusion, and confirmed that both PGA1 as well as TRI are potential drugs for the treatment of myocardial ischemia reperfusion.

In the present study, PGA1 and TRI inhibited the apoptosis of rat CMVECs by upregulation of the expression of Bcl-2 mRNA. PGA1 and TRI, not only alleviated the injury of vascular endothelial cells in hypoxia and oxygen, but also protected the function of endothelial cells. Thus, both have wide application prospects in the treatment of myocardial ischemia reperfusion injury.
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###### 

RT-PCR primer sequences of Bcl-2 and β-actin mRNA.

  Gene        Primer sequence (5′-3′)
  ----------- ---------------------------------
  *Bcl-2*     Forward: GAGGATTGTGGCCTTCTTTG
              Reverse: GTTCCACAAAGGCATCCCAG
  β-*actin*   Forward: TCAGGTCATCACTATCGGCAAT
              Reverse: AAAGAAAGGGTGTAAAACGCA
